NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
January 30, 2025 — Stonegate Capital Partners initiates coverage on Alpha Cognition Inc. (NASDAQ: ACOG) and its flagship Alzheimer's therapy ZUNVEYL. With FDA approval and upcoming launch, Alpha Cognition aims to provide a well-tolerated treatment option for Alzheimer's patients, addressing the high discontinuation rate due to side effects.
January 30, 2025 — American Heart Association announces 2025 Impact with Heart awards for innovative healthcare solutions from Sober Sidekick and OxiWear. Learn how these initiatives are driving equitable health outcomes and addressing cardiovascular disease.
January 30, 2025 — Wire Industries partners with Birches Health to promote responsible gaming and provide resources for problem gambling. The collaboration aims to raise awareness, offer guidance, and integrate clinical materials into their platforms, fostering a culture of sustainable play.
January 30, 2025 — Shear Kershman Labs, Texas A&M College of Dentistry, and Innovative MedTech Inc. partner to revolutionize oral healthcare with a bioequivalency study for Oral Thrush. The collaboration promises innovative drug delivery solutions and enhanced patient care.
January 30, 2025 — Study reveals the effectiveness of F.A.S.T. and BE-FAST acronyms in promoting immediate 911 calls for stroke symptoms. Findings show F.A.S.T. outperformed BE-FAST in aiding symptom recall. Learn more about the impact of recognizing stroke signs early.
January 30, 2025 — Regular flossing may lower stroke risk, according to a study presented at the American Stroke Association’s International Stroke Conference 2025. The study found that flossing was associated with a 22% lower risk of ischemic stroke and a 44% lower risk of cardioembolic stroke.
January 30, 2025 — Short telomeres, protective caps on chromosomes, may signal increased risk of stroke, dementia, and late-life depression. Learn how lifestyle choices can counteract biological aging effects.
January 30, 2025 — New study reveals the connection between Streptococcus anginosus bacteria in the gut and increased stroke risk. Understanding this link can lead to improved prevention strategies and personalized preventive measures to reduce the risk of stroke.
January 30, 2025 — Discover how a progressive walking exercise program combined with standard physical therapy can significantly improve the quality of life and mobility in stroke survivors. Learn about the positive results of a study presented at the American Stroke Association’s International Stroke Conference 2025.
January 30, 2025 — A groundbreaking study reveals how a blood test detecting the brain protein GFAP could revolutionize stroke care by differentiating between stroke types before patients reach the hospital, potentially improving outcomes and reducing long-term disability.
January 30, 2025 — Preliminary research presented at the American Stroke Association's International Stroke Conference 2025 reveals the potential of an AI model using ECG data to predict cognitive decline. This innovative approach could transform early detection and intervention for cognitive impairment, offering a novel method for assessing cognition and potentially improving treatment outcomes.
January 30, 2025 — Closely following a Mediterranean diet has shown to improve brain health in Hispanic/Latino adults, according to a preliminary study presented at the American Stroke Association’s International Stroke Conference 2025. The study emphasizes the independent positive impact of the diet on brain health, urging individuals to consider adopting this dietary pattern for better brain integrity.
January 30, 2025 — Propranolol, a medication used for high blood pressure and migraines, may lower ischemic stroke risk in women with migraines. The study presented at the American Stroke Association’s International Stroke Conference 2025 suggests a stronger protective effect of propranolol for ischemic stroke in women, emphasizing the importance of preventive treatments for migraine-related stroke risk.
January 30, 2025 — New research presented at the International Stroke Conference 2025 highlights the association between childhood stroke and increased risk of anxiety, depression, and other mental health challenges. Understanding these implications is crucial for healthcare providers and parents in supporting the well-being of young stroke survivors.
January 30, 2025 — The Colorado Rural Health Center's 2025 Snapshot of Rural Health offers crucial insights into rural healthcare in Colorado, including demographic trends and chronic disease data. This report serves as a valuable resource for policymakers and healthcare providers to address the healthcare needs of rural Coloradans.
January 30, 2025 — TreatmentRehabCenters.org introduces a new platform connecting individuals with top rehab centers in 2025. Offering detailed profiles, expert advice, and personalized support, the site aims to guide visitors towards effective and compassionate care for addiction and mental health.
January 29, 2025 — New survey data from the American Heart Association reveals a rise in bystander confidence for providing CPR during emergencies. Learn how the organization's efforts to educate and equip individuals with lifesaving skills are making a difference in improving survival rates for sudden cardiac arrest.
January 29, 2025 — Silexion Therapeutics makes strides in precision oncology with the breakthrough of SIL-204, demonstrating promising results in treating KRAS-driven cancers. The company's latest preclinical findings show significant tumor growth reduction and sustained therapeutic levels, positioning it as a key player in the evolving landscape of targeted cancer therapies.
January 29, 2025 — Centre for Neuro Skills has been accredited by the Behavioral Health Center of Excellence for their commitment to excellence in applied behavior analysis services. This news showcases CNS' dedication to providing top-quality rehabilitation services and creating valuable learning opportunities for students in the field.
January 29, 2025 — GeoVax Labs, Inc. highlights its commitment to reinforcing America's biosecurity through the development of the GEO-MVA vaccine, addressing critical vulnerabilities in the U.S. vaccine supply and national preparedness. The company's efforts to enhance domestic vaccine production align with national initiatives to strengthen U.S. biomanufacturing resilience and achieve vaccine independence.